12월 8, 2022 Certara Announces the Completion of Arsenal Capital Partners’ Investment and the Appointment of David Spaight to the Board of Directors
11월 7, 2022 Arsenal Capital Partners Increases Investment in Global Biosimulation Leader Certara with $449M Stock Purchase
10월 19, 2022 Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) Renews Licenses of Certara’s Software for Evaluating Regulatory Submissions